88 results on '"Ferri C"'
Search Results
2. AB1181 THE BURDEN OF POST-SARS-COV2 VACCINE COMPLICATIONS AND NEWLY DIAGNOSED IMMUNE-MEDIATED INFLAMMATORY DISEASES
3. POS1214 COVID-19 VACCINATION RATE AND SAFETY PROFILE IN PATIENTS AFFECTED BY MIXED CRYOGLOBULINEMIC VASCULITIS.
4. POS0992 CLINICAL AND IMAGING FEATURES IN SPONDYLOARTHRITIS PATIENTS WITH AND WITHOUT HLA-B27 AND HLA-B51: A VALIDATION COHORT
5. AB0524 RELATIONSHIP BETWEEN SERUM URIC ACID, CARDIOVASCULAR RISK AND INFLAMMATORY STATUS IN PRIMARY SJÖGREN’S SYNDROME
6. POS0723 DIETARY HABITS AND THE IMPACT ON CLINICAL FEATURES IN PRIMARY SJOGREN’S SYNDROME
7. POS1267 LONG-TERM SURVEY STUDY OF THE IMPACT OF COVID-19 ON SYSTEMIC AUTOIMMUNE DISEASES. LOW DEATH RATE DESPITE THE INCREASED PREVALENCE OF SYMPTOMATIC INFECTION. ROLE OF PRE-EXISTING INTERSTITIAL LUNG DISEASE AND ONGOING TREATMENTS.
8. COVID-19 in Italian patients with rheumatic autoimmune systemic diseases
9. AB0652 FERRITIN IS ASSOCIATED WITH THE SEVERITY OF LUNG INVOLVEMENT BUT NOT WITH WORSE PROGNOSIS IN PATIENTS WITH COVID-19: DATA FROM TWO ITALIAN COVID-19 UNITS
10. POS1246 COVID-19 IN ITALIAN PATIENTS WITH RHEUMATIC AUTOIMMUNE SYSTEMIC DISEASES: RESULTS OF A NATIONWIDE SURVEY STUDY
11. Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia
12. Systemic sclerosis following human cytomegalovirus infection
13. Cryoglobulinaemic vasculitis as presenting manifestation of infective endocarditis
14. European multicentre study to define disease activity criteria for systemic sclerosis. * II. Identification of disease activity variables and development of preliminary activity indexes
15. European multicentre study to define disease activity criteria for systemic sclerosis. * I. Clinical and epidemiological features of 290 patients from 19 centres
16. Microvascular involvement in systemic sclerosis: laser Doppler evaluation of reactivity to acetylcholine and sodium nitroprusside by iontophoresis
17. Wegener's granulomatosis of the elderly: a case report of uncommon severe gangrene of the feet
18. AB0637 Iloprost (ILO) in Systemic Sclerosis (SSC): The Safety Experience of Two Italian Centres
19. AB0623 Treatment of Scleroderma-Related Digital Ulcers with Iloprost: A Cohort Study
20. Plasma endothelin-1 levels in patients with systemic sclerosis: influence of pulmonary or systemic arterial hypertension
21. URIC ACID LEVELS, CARDIOVASCULAR RISK AND DISEASE ACTIVITY: THE BERMUDA TRIANGLE IN PRIMARY SJÖGREN'S SYNDROME.
22. DYSPHAGIA AND RELATED SYMPTOMS ARE FREQUENT, SEVERE AND HEAVILY AFFECT THE QUALITY OF LIFE OF PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME.
23. A SYSTEMATIC LITERATURE REVIEW OF RANDOMISED CONTROLLED TRIALS EVALUATING COLCHICINE FOR CARDIOVASCULAR PREVENTION: THERE IS AN ELEPHANT IN THE ROOM.
24. AB0716 Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline
25. AB0416 Early Good Eular Response Predicts Low/Remission Disease State in Rheumatoid Arthritis Patients on Treatment with Certolizumab in Real Life Settings. Data from Italian Registry Gisea: Table 1
26. SAT0621 Validation Study of Predictive Value of Capillaroscopic Skin Ulcer Risk Index (CSURI) in Scleroderma Patients Treated with Bosentan
27. SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies
28. AB0688 Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial
29. OP0274 Cryoglobulinemic Vasculitis and Primary sjögren's Syndrome are Independent Risk Factors for Lymphoma in a Large Worldwide Population of Patients with Positive Serum Cryoglobulins
30. SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients
31. FRI0451 Unclassifiable Interstitial Lung Disease or Undifferentiated Connective Tissue Disease? A Challenging Differential Diagnosis
32. AB0381 Long-Term Clinical Effectiveness of Adalimumab, Etanercept, and Infliximab in Rheumatoid Arthritis (RA): an Observational Study from Italian Register, Gisea
33. AB0342 Rheumatoid Arthritis Related Interstitial Lung Disease. Radiological Patterns and Correlations with Clinical, Serological and Demographic Features of Disease
34. OP0228 Rituximab Monotherapy of Severe Hcv-Related Cryoglobulinemic Vasculitis for More than 2 Years: Follow-Up of A Randomized Controlled Multicentre Study
35. THU0395 Adult Onset Still's Disease: A Multicenter Retrospective Cohort Study of 233 Italian Patients
36. SAT0298 Nailfold Capillaroscopic Alterations in Dermatomyositis and Polymyositis
37. OP0275 Nailfold Videocapillaroscopy and Other Predictive Factors Associated with New Digital Ulcers in Systemic Sclerosis: Data from the Cap Study
38. SAT0175 Results of the Classification Criteria for Cryoglobulinemic Vasculitis Validation Study
39. AB0844-HPR Dance class dedicated to scleroderma patients: joint evaluation, functional and quality of life before and after treatment – clinical trial
40. FRI0234 Complement depletion in rheumatoid arthritis patients treated with tocilizumab: a marker of clinical efficacy?
41. SAT0029 Mesenchymal stem cells modulate in vitro fibroblast activity in systemic sclerosis
42. AB0465 Etanercept therapy in rheumatoid arthritis patients with moderate or severe disease activity
43. AB0541 Factors associated with selection of rituximab vs alternative TNF inhibitor (TNFI) following TNFI failure in patients with rheumatoid arthritis: Sub-analysis of switch-RA, a global, comparative effectiveness observational study
44. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study
45. Preliminary classification criteria for the cryoglobulinaemic vasculitis
46. Heart involvement in systemic sclerosis: an ultrasonic tissue characterisation study
47. Microvascular involvement in systemic sclerosis: laser Doppler evaluation of reactivity to acetylcholine and sodium nitroprusside by iontophoresis
48. Effect of isradipine on endothelin-1 plasma concentrations in patients with Raynaud's phenomenon.
49. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study.
50. European multicentre study to define disease activity criteria for systemic sclerosis.* I. Clinical and epidemiological features of 290 patients from 19 centres.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.